Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC50 of cyclopofol with different esketamine doses for painless hysteroscopy
ChiCTR2300077542Phase 4Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Nov 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol and esketamine (3 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Median effective concentration (EC50) of cyclopofol. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
ciprofolesketamine
Beyond the preview
Go deeper on ChiCTR2300077542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077542.